Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 139


Novel Crossing System for Chronic Total Occlusion Recanalization: First-in-Man Experience With the SoundBite Crossing System.

Benko A, Bérubé S, Buller CE, Dion S, Riel LP, Brouillette M, Généreux P.

J Invasive Cardiol. 2017 Feb;29(2):E17-E20.


Transcatheter aortic valve replacement with the Portico valve: one-year results of the early Canadian experience.

Perlman GY, Cheung A, Dumont E, Stub D, Dvir D, Del Trigo M, Pelletier M, Alnasser S, Ye J, Wood D, Thompson C, Blanke P, Leipsic J, Seidman MA, LeBlanc H, Buller CE, Rodés-Cabau J, Webb JG.

EuroIntervention. 2017 Jan 20;12(13):1653-1659. doi: 10.4244/EIJ-D-16-00299.


Repatriation to referral hospital after reperfusion of STEMI patients transferred for primary percutaneous coronary intervention: Insights of a Canadian regional STEMI care system.

Ting R, Tejpal A, Finken L, Fisher M, Lefkowitz C, Parthasarathy H, Fallis B, Fosbol EL, Al-Shehri M, Kutryk M, Buller CE, Fam N, Graham JJ, Cheema AN, Bagai A.

Am Heart J. 2016 Jul;177:145-52. doi: 10.1016/j.ahj.2016.04.017.


Balloon-Expandable and Self-Expanding Transcatheter Heart Valves: Friend or Foe?

Alnasser SM, Benhomeid O, Peterson MD, Buller CE, Latter D, Deva DP, Cheema AN.

J Heart Valve Dis. 2015 Sep;24(5):640-3.


Efficacy of an early invasive strategy after fibrinolysis in ST-elevation myocardial infarction relative to the extent of coronary artery disease.

Elbarouni B, Cantor WJ, Ducas J, Borgundvaag B, Džavík V, Heffernan M, Buller CE, Langer A, Goodman SG, Yan AT; TRANSFER-AMI Trial Investigators..

Can J Cardiol. 2014 Dec;30(12):1555-61. doi: 10.1016/j.cjca.2014.09.001.


Spontaneous coronary artery dissection: association with predisposing arteriopathies and precipitating stressors and cardiovascular outcomes.

Saw J, Aymong E, Sedlak T, Buller CE, Starovoytov A, Ricci D, Robinson S, Vuurmans T, Gao M, Humphries K, Mancini GB.

Circ Cardiovasc Interv. 2014 Oct;7(5):645-55. doi: 10.1161/CIRCINTERVENTIONS.114.001760.


Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial.

Dangas GD, Farkouh ME, Sleeper LA, Yang M, Schoos MM, Macaya C, Abizaid A, Buller CE, Devlin G, Rodriguez AE, Lansky AJ, Siami FS, Domanski M, Fuster V; FREEDOM Investigators..

J Am Coll Cardiol. 2014 Sep 23;64(12):1189-97. doi: 10.1016/j.jacc.2014.06.1182.


Chronic total occlusion percutaneous coronary intervention case selection and techniques for the antegrade-only operator.

Rinfret S, Joyal D, Spratt JC, Buller CE.

Catheter Cardiovasc Interv. 2015 Feb 15;85(3):408-15. doi: 10.1002/ccd.25611. Review.


Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI study.

Povsic TJ, Vavalle JP, Alexander JH, Aberle LH, Zelenkofske SL, Becker RC, Buller CE, Cohen MG, Cornel JH, Kasprzak JD, Montalescot G, Fail PS, Sarembock IJ, Mehran R; RADAR Investigators..

EuroIntervention. 2014 Aug;10(4):431-8. doi: 10.4244/EIJY14M06_01.


Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled trial.

Russo JJ, Goodman SG, Cantor WJ, Fitchett D, Heffernan M, Borgundvaag B, Ducas J, Cohen EA, Džavik V, Mehta SR, Buller CE, Yan AT; TRANSFER-AMI investigators..

Heart. 2014 Jun;100(11):873-80. doi: 10.1136/heartjnl-2013-305231.


Safety of very early sheath removal in patients treated with REG1 for acute coronary syndromes: insights from the RADAR trial.

Vavalle JP, Povsic TJ, Aberle LH, Zelenkofske SL, Mehran R, Kasprzak JD, Bode C, Buller CE, Montalescot G, Cornel JH, Becker RC, Alexander JH, Cohen MG.

J Invasive Cardiol. 2013 Nov;25(11):593-9.


Reply: To PMID 23266235.

Saw J, Ricci D, Starovoytov A, Fox R, Buller CE.

JACC Cardiovasc Interv. 2013 Jun;6(6):638-9. doi: 10.1016/j.jcin.2013.03.007. No abstract available.


Percutaneous revascularization and long term clinical outcomes of diabetic patients randomized in the Occluded Artery Trial (OAT).

Overgaard CB, Džavík V, Buller CE, Liu L, Banasiak W, Devlin G, Maggioni AP, Leor J, Burton JR, Reis G, Ruzyllo W, Forman SA, Lamas GA, Hochman JS; OAT Investigators..

Int J Cardiol. 2013 Oct 3;168(3):2416-22. doi: 10.1016/j.ijcard.2013.02.004.


Spontaneous coronary artery dissection: prevalence of predisposing conditions including fibromuscular dysplasia in a tertiary center cohort.

Saw J, Ricci D, Starovoytov A, Fox R, Buller CE.

JACC Cardiovasc Interv. 2013 Jan;6(1):44-52. doi: 10.1016/j.jcin.2012.08.017.


A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial.

Povsic TJ, Vavalle JP, Aberle LH, Kasprzak JD, Cohen MG, Mehran R, Bode C, Buller CE, Montalescot G, Cornel JH, Rynkiewicz A, Ring ME, Zeymer U, Natarajan M, Delarche N, Zelenkofske SL, Becker RC, Alexander JH; RADAR Investigators..

Eur Heart J. 2013 Aug;34(31):2481-9. doi: 10.1093/eurheartj/ehs232.


Long-term outcomes after a strategy of percutaneous coronary intervention of the infarct-related artery with drug-eluting stents or bare metal stents vs medical therapy alone in the Occluded Artery Trial (OAT).

Freixa X, Džavík V, Forman SA, Rankin JM, Buller CE, Cantor WJ, Ruzyllo W, Reynolds HR, Lamas GA, Hochman JS.

Am Heart J. 2012 Jun;163(6):1011-8. doi: 10.1016/j.ahj.2012.03.008. Erratum in: Am Heart J. 2013 Apr;165(4):638.


Pan-Canadian cardiovascular data definitions and quality indicators: a status update.

Johnstone DE, Buller CE; National Steering Committees on Quality Indicators and Data Definitions, Canadian Cardiovascular Society..

Can J Cardiol. 2012 Sep-Oct;28(5):599-601. doi: 10.1016/j.cjca.2012.01.024. Review.


A percutaneous treatment algorithm for crossing coronary chronic total occlusions.

Brilakis ES, Grantham JA, Rinfret S, Wyman RM, Burke MN, Karmpaliotis D, Lembo N, Pershad A, Kandzari DE, Buller CE, DeMartini T, Lombardi WL, Thompson CA.

JACC Cardiovasc Interv. 2012 Apr;5(4):367-79. doi: 10.1016/j.jcin.2012.02.006. Review.


Anticoagulation after subcutaneous enoxaparin is time sensitive in STEMI patients treated with tenecteplase.

Welsh RC, Westerhout CM, Buller CE, O'Neill B, Gordon P, Armstrong PW.

J Thromb Thrombolysis. 2012 Jul;34(1):126-31. doi: 10.1007/s11239-012-0697-7.

Items per page

Supplemental Content

Loading ...
Support Center